Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 1
2009 1
2010 4
2012 2
2013 1
2014 2
2015 3
2016 3
2017 2
2018 2
2019 3
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense.
Garaude J, Acín-Pérez R, Martínez-Cano S, Enamorado M, Ugolini M, Nistal-Villán E, Hervás-Stubbs S, Pelegrín P, Sander LE, Enríquez JA, Sancho D. Garaude J, et al. Among authors: Nistal-Villan E. Nat Immunol. 2016 Sep;17(9):1037-1045. doi: 10.1038/ni.3509. Epub 2016 Jun 27. Nat Immunol. 2016. PMID: 27348412 Free PMC article.
miR-146a targets c-met and abolishes colorectal cancer liver metastasis.
Bleau AM, Redrado M, Nistal-Villan E, Villalba M, Exposito F, Redin E, de Aberasturi AL, Larzabal L, Freire J, Gomez-Roman J, Calvo A. Bleau AM, et al. Among authors: Nistal-Villan E. Cancer Lett. 2018 Feb 1;414:257-267. doi: 10.1016/j.canlet.2017.11.008. Epub 2017 Nov 11. Cancer Lett. 2018. PMID: 29133238
The transcription factor NFAT5 limits infection-induced type I interferon responses.
Huerga Encabo H, Traveset L, Argilaguet J, Angulo A, Nistal-Villán E, Jaiswal R, Escalante CR, Gekas C, Meyerhans A, Aramburu J, López-Rodríguez C. Huerga Encabo H, et al. Among authors: Nistal-Villan E. J Exp Med. 2020 Mar 2;217(3):jem.20190449. doi: 10.1084/jem.20190449. J Exp Med. 2020. PMID: 31816635
Oncolytic bacteria: past, present and future.
Rius-Rocabert S, Llinares Pinel F, Pozuelo MJ, García A, Nistal-Villan E. Rius-Rocabert S, et al. Among authors: Nistal-Villan E. FEMS Microbiol Lett. 2019 Jun 1;366(12):fnz136. doi: 10.1093/femsle/fnz136. FEMS Microbiol Lett. 2019. PMID: 31226708
A Versatile Vector for In Vivo Monitoring of Type I Interferon Induction and Signaling.
Nistal-Villan E, Poutou J, Rodríguez-Garcia E, Buñuales M, Carte-Abad B, Prieto J, Gonzalez-Aseguinolaza G, Hernandez-Alcoceba R, Larrea E. Nistal-Villan E, et al. PLoS One. 2016 Mar 23;11(3):e0152031. doi: 10.1371/journal.pone.0152031. eCollection 2016. PLoS One. 2016. PMID: 27007218 Free PMC article.
Interferon alpha bioactivity critically depends on Scavenger receptor class B type I function.
Vasquez M, Fioravanti J, Aranda F, Paredes V, Gomar C, Ardaiz N, Fernandez-Ruiz V, Méndez M, Nistal-Villan E, Larrea E, Gao Q, Gonzalez-Aseguinolaza G, Prieto J, Berraondo P. Vasquez M, et al. Among authors: Nistal-Villan E. Oncoimmunology. 2016 Jun 29;5(8):e1196309. doi: 10.1080/2162402X.2016.1196309. eCollection 2016 Aug. Oncoimmunology. 2016. PMID: 27622065 Free PMC article.
TMEM173 Alternative Spliced Isoforms Modulate Viral Replication through the STING Pathway.
Rodríguez-García E, Olagüe C, Ríus-Rocabert S, Ferrero R, Llorens C, Larrea E, Fortes P, Prieto J, González-Aseguinolaza G, Nistal-Villan E. Rodríguez-García E, et al. Among authors: Nistal-Villan E. Immunohorizons. 2018 Dec 11;2(11):363-376. doi: 10.4049/immunohorizons.1800068. Immunohorizons. 2018. PMID: 31026807
A Digital Method to Quantify Type I Interferon.
Rius-Rocabert S, Presa JL, Esteban-Rubio S, Ayuso-Sacido A, Nistal-Villan E. Rius-Rocabert S, et al. Among authors: Nistal-Villan E. J Interferon Cytokine Res. 2019 Nov;39(11):711-719. doi: 10.1089/jir.2019.0046. Epub 2019 Jul 3. J Interferon Cytokine Res. 2019. PMID: 31268382
Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model.
Nistal-Villan E, Bunuales M, Poutou J, Gonzalez-Aparicio M, Bravo-Perez C, Quetglas JI, Carte B, Gonzalez-Aseguinolaza G, Prieto J, Larrea E, Hernandez-Alcoceba R. Nistal-Villan E, et al. Mol Cancer. 2015 Dec 16;14:210. doi: 10.1186/s12943-015-0479-x. Mol Cancer. 2015. PMID: 26671477 Free PMC article.
28 results
Jump to page
Feedback